{"studyId":"summit_2018","cancerTypeId":"mixed","name":"SUMMIT - Neratinib Basket Study (Multi-Institute, Nature 2018)","description":"MSK-IMPACT sequencing of 86 patients with HER2- and HER3-mutant cancers","publicStudy":true,"pmid":"29420467","citation":"Hyman et al. Nature 2018","groups":"","status":1,"importDate":"2026-01-13 14:59:54","allSampleCount":141,"sequencedSampleCount":106,"cnaSampleCount":106,"mrnaRnaSeqSampleCount":0,"mrnaRnaSeqV2SampleCount":0,"mrnaMicroarraySampleCount":0,"miRnaSampleCount":0,"methylationHm27SampleCount":0,"rppaSampleCount":0,"massSpectrometrySampleCount":0,"completeSampleCount":0,"referenceGenome":"hg19","treatmentCount":0,"structuralVariantCount":1,"cancerType":{"id":"mixed","name":"Mixed Cancer Types","dedicatedColor":"Black","shortName":"MIXED","parent":"other"},"readPermission":true,"resourceCounts":[]}